Wolverine Trading’s Supernus Pharmaceuticals SUPN Stock Holding History

Wolverine Trading’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,641	Closed	-$234K	–	6671
2021 Q1	$200K	Buy	+7,641	New	+$214K	﹤0.01%	5055
2020 Q1	–	Sell	-13,386	Closed	-$281K	–	5257
2019 Q4	$312K	Buy	+13,386	New	+$325K	﹤0.01%	3550
2019 Q3	–	Sell	-11,062	Closed	-$328K	–	4977
2019 Q2	$366K	Sell	11,062 -3,999	-27%	-$137K	﹤0.01%	3055
2019 Q1	$528K	Sell	15,061 -7,711	-34%	-$287K	﹤0.01%	2711
2018 Q4	$737K	Buy	22,772 +13,970	+159%	+$601K	﹤0.01%	2262
2018 Q3	$443K	Buy	+8,802	New	+$435K	﹤0.01%	3253
2016 Q4	–	Sell	-8,672	Closed	-$194K	–	5113
2016 Q3	$214K	Sell	8,672 -16,711	-66%	-$378K	﹤0.01%	3738
2016 Q2	$504K	Buy	+25,383	New	+$450K	﹤0.01%	2218

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's SUPN Position: Q2 2021 in Review

Wolverine Trading sold out of Supernus Pharmaceuticals (SUPN) in Q2 2021, closing a stake of 7,641 shares — an estimated $234K sold.

Wolverine Trading first reported a position in SUPN in Q2 2016 and held it in 8 quarters. The position peaked at $737K in Q4 2018. 226 funds tracked by Wall St. Rank hold SUPN as of Q2 2021.

Wolverine Trading reported no remaining Supernus Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Wolverine Trading sold 7,641 Supernus Pharmaceuticals shares in Q2 2021, an estimated $234K.
Wolverine Trading first reported a position in Supernus Pharmaceuticals in Q2 2016 and held it in 8 quarters.
Wolverine Trading's Supernus Pharmaceuticals position peaked at $737K in Q4 2018.
226 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2021.

Based on Wolverine Trading's 13F filing for Q2 2021, filed 6 Aug 2021.